Trial Profile
Effect of combination of atazanavir, tenofovir and lamivudine in HIV patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Feb 2015
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary) ; Tenofovir disoproxil fumarate (Primary) ; Lamivudine; Nucleotide reverse transcriptase inhibitors
- Indications HIV infections
- Focus Pharmacokinetics; Therapeutic Use
- 18 Feb 2015 New trial record